Thiazolidinediones activate the nuclear receptor PPAR-γ, which brings about increased glucose tolerance and glucose sensitivity. Endogenous ligand can achieve the same effect under certain conditions, suggesting a different approach to activating the same pathway.
No takes yet. Share an insight, caveat, or question.
Anthony N. Hollenberg (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: